SITC-AACR Workshop: The Cancer Biology Underlying Immunotherapy-Induced Autoimmunity

Starts:  Mar 4, 2020 1:00 PM (CT)
Ends:  Mar 6, 2020 1:00 PM (CT)

The Society for Immunotherapy of Cancer (SITC) and the American Association for Cancer Research (AACR) will host a collaborative workshop, The Cancer Biology Underlying Immunotherapy-Induced Autoimmunity, March 4–6, 2020, in Houston, which will focus on immune-related adverse events (irAEs).

 

This partnership is uniquely suited to address this important topic as the members of these two societies are the leaders in immunotherapy and cancer research, with the required expertise to elucidate the mechanisms of irAEs.

The SITC-AACR workshop: The Cancer Biology Underlying Immunotherapy-induced Autoimmunity, will feature 40 of the leading researchers and clinicians in immunotherapy, autoimmunity and other relevant disciplines.

Workshop Organizers:

  • Lisa H. Butterfield, PhD*Parker Institute for Cancer Immunotherapy; University of California—San Francisco; Past-president, SITC
  • Elizabeth M. Jaffee, MD* Sidney Kimmel Cancer Center, Johns Hopkins Universit; Past-president, AACR
  • Arlene S. Sharpe, MD, PhD Sharpe Laboratory, Harvard Medical School

*Denotes SITC member.

Location

The Houstonian
111 N Post Oak Ln
Houston, TX 77024